Figure 2.
Autophagic switch from a cytoprotective to a cytotoxic function. Cytoprotective autophagy prevents the cancer cell death and is induced by some particular conditions in various cancer models. All the conditions leading to cytoprotective autophagy are colored in red. When an autophagic switch occurs, cytoprotective autophagy turns into cytotoxic autophagy, and helps to kill the cancer cells. All the conditions leading to the induction of cytotoxic autophagy are colored in green.
Cancer model | Condition 1 | Condition 2 | Reference |
---|---|---|---|
Breast cancer | Radiotherapy | Radiotherapy + vitamin B3 | [62,63] |
Breast cancer | Gemcitabine | Gemcitabine + Estrogen receptor signaling | [65] |
Non Small Cell Lung cancer | Low inhibition of EGFR signaling | High inhibition of EGFR signaling | [66,67] |
Colon cancer | Topotecan | Topotecan + mutated p53 status | [70] |
Breast cancer Neuroblastoma Multiple myeloma |
Beclin 1/Bcl-2 complex | Disruption of Beclin 1/Bcl-2 complex | [74] [75] [76] |
Breast cancer Colon cancer |
Sphingosine 1 phosphate signaling | Ceramide signaling | [79] [80] |
Acute myeloid leukemia | Strong mTOR inhibition | Low mTOR inhibition | [81] |